Evidence map›Paper›PMID 10627549›Full record

ArticleJournal of virology2000

Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.

J Singh, T Compton

Abstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. HCMV Envelope Glycoprotein Diversity Demystified.Frontiers in microbiology · 2019
    Article
  3. Development of novel vaccines against human cytomegalovirus.Human vaccines & immunotherapeutics · 2019
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J SinghDepartment of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin 53706, USA.
T Compton

Funding

Role of Glycoprotein B in HCMV infectionR01AI034998 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KALEJTA, ROBERT F · 1995 to 2010
$2.8M
VIRAL ONCOLOGYT32CA009075 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI MERTZ, JANET ELAINE · 1985 to 2005
$1.1M
NCI NIH HHS 2-T32-CA09075-21NCI NIH HHS T32 CA009075NIAID NIH HHS R01 AI034998NIAID NIH HHS R01 AI-34998
6 · The paper itself

Abstract

Glycoprotein B (gB; gpUL55) of human cytomegalovirus (HCMV) plays a critical role in virus entry and cell-to-cell spread of infection. To define the structure-function relationships in gB, a panel of linker-insertion mutations was generated throughout the coding region. This strategy yielded a panel of 22 mutants with four amino acid insertions and 3 large truncation mutants. Assessment of the mutant proteins' biosynthetic properties and folding patterns analyzed in context with predicted secondary features revealed novel insights into gB's structure and trafficking properties. All of the insertion mutants were able to assemble into oligomers, suggesting that oligomerization is tolerant of small insertions and/or that multiple regions of the protein may be involved. Computer algorithm predictions of gB's secondary structure indicate that the furin-recognized cleavage site falls within an exposed loop. This loop may be particularly sensitive to structural alterations, since insertions upstream and downstream of the cleavage site rendered the mutant proteins cleavage defective. In addition, a strong correlation existed between terminal folding and cleavage of gB. Interestingly, terminal folding was not correlated with delivery to the cell surface but may influence the rate of transport to the cell surface. Nine mutants, containing insertions in both the extracellular and intracellular portions of gB, retained wild-type structural properties. This panel of characterized gB mutants, the first of this type for an HCMV protein, will be a useful tool in dissecting the role of gB during HCMV infection.

Indexed as

Mutagenesis, InsertionalAntibodies, MonoclonalBiotinylationCell LineCell MembraneCytomegalovirusDimerizationElectrophoresis, Polyacrylamide GelEndopeptidase KHumansImmunoblottingProtein Processing, Post-TranslationalStructure-Activity RelationshipViral Envelope ProteinsAntibodies, MonoclonalEndopeptidase Kglycoprotein B, SimplexvirusViral Envelope Proteins

Identifiers

PMID10627549
PMCPMC111473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.